Innospec Inc. (IOSP) Financials
IOSP Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2023-12-31 | 1.7 billion | 557.8 million |
| 2023-09-30 | 1.6 billion | 490.5 million |
| 2023-06-30 | 1.6 billion | 516.0 million |
| 2023-03-31 | 1.6 billion | 543.5 million |
IOSP Free Cash Flow and Stock based compensation
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2023-12-31 | 51.2 million | 2.1 million |
| 2023-09-30 | 41.4 million | 2.0 million |
| 2023-06-30 | 37.7 million | 2.0 million |
| 2023-03-31 | -200000 | 1.9 million |
IOSP Net Income
| Date | Net Income |
|---|---|
| 2023-12-31 | 37.8 million |
| 2023-09-30 | 39.2 million |
| 2023-06-30 | 28.9 million |
| 2023-03-31 | 33.2 million |
IOSP Cash and Debt
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2023-12-31 | 203.7 million | - | 45.2 million |
| 2023-09-30 | 207.2 million | - | 42.5 million |
| 2023-06-30 | 165.9 million | - | 45.9 million |
| 2023-03-31 | 147.5 million | - | 49.0 million |
IOSP Shares Outstanding
IOSP Expenses
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2023-12-31 | 21.2 million | 8.9 million | 102.3 million | - |
| 2023-09-30 | 16.7 million | 11.6 million | 83.7 million | - |
| 2023-06-30 | 17.3 million | 10.6 million | 105.6 million | - |
| 2023-03-31 | 22.0 million | 10.6 million | 96.2 million | - |
IOSP Cost of Revenue
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2023-12-31 | 494.7 million | 339.0 million |
| 2023-09-30 | 464.1 million | 326.9 million |
| 2023-06-30 | 480.4 million | 330.0 million |
| 2023-03-31 | 509.6 million | 361.8 million |
IOSP
List: Contenders
Price: $120.10
Dividend Yield: 0.01%
Forward Dividend Yield: 1.20%
Payout Ratio: 28.40%
Dividend Per Share: 1.44 USD
Earnings Per Share: 5.57 USD
P/E Ratio: 24.82
Exchange: NMS
Sector: Basic Materials
Industry: Specialty Chemicals
Volume: 13935
Ebitda: 51.6 millionMarket Capitalization: 3.0 billion
Average Dividend Frequency: 2
Years Paying Dividends: 11
DGR3: 10.68%
DGR5: 9.72%